Newsfile Corp
12 Nov 2026, 22:54 UTC · 4h ago
Did You Lose Money on Tenax Therapeutics, Inc. Stock? Faruqi & Faruqi, LLP Reminds Investors of December 28, 2026 Lead Plaintiff Deadline in Securities Class Action After 89.77% Share Price Decline
Impact · against what's priced in
The news is a non-event for Tenax Therapeutics' valuation. The massive share price collapse and the existence of the securities class action are already reflected in the stock's current level; the reminder of a procedural filing deadline provides no new material impact.
- TENX−0.05
No priced-in read yet





